Protein farnesyltransferase (FTase) is an enzyme responsible for posttranslational modification of proteins carrying a carboxy-terminal CaaX motif. Farnesylation allows substrates to interact with membranes and protein targets. Using gene-targeted mice, we report that FTase is essential for embryonic development, but dispensable for adult homeostasis. Six-month-old FTase-deficient mice display delayed wound healing and maturation defects in erythroid cells. Embryonic fibroblasts lacking FTase have a flat morphology and reduced motility and proliferation rates. Ablation of FTase in two ras oncogene-dependent tumor models has no significant consequences for tumor initiation. However, elimination of FTase during tumor progression had a limited but significant inhibitory effect. These results should help to better understand the role of protein farnesylation in normal tissues and in tumor development.
Introduction
cellular pathways whose dysfunction often leads to disease. Among the best-known farnesylated proteins are Ras proteins, Posttranslational modification of eukaryotic proteins by isonuclear lamins, kinetochore proteins such as CENP-E and prenyl residues was firmly established in the late 80s (reviewed CENP-F, cGMP phosphodiesterase α, the γ subunits of in Glomset et al., 1990; Zhang and Casey, 1996) . Eukaryotic two heterotrimeric G proteins, DnaJ heat shock protein homoorganisms, from yeast to man, contain three protein isoprenlogs, rhodopsin kinase, and peroxisomal membrane proteins. yltransferases, designated protein farnesyltransferase (FTase), GGTase I geranylgeranylates most of the members of the Rho protein geranylgeranyltransferase I (GGTase I), and protein gersubfamily of small GTPases, certain γ subunits of heterotrianylgeranyltransferase II (GGTase II). These enzymes are clasmeric G proteins, and cGMP phosphodiesterase α (Reid et al., sified based on the isoprenyl group, farnesyl (C 15 ) or geranyl-2004) . Whereas FTase recognizes proteins with CaaX motifs in which X is a serine, methionine, alanine, or glutamine residue, geranyl (C 20 ), that they use as a substrate as well as on the motif that they recognize. FTase and GGTase I (collectively GGTase I favors CaaX motifs in which the carboxy-terminal residue is a leucine (Seabra et al., 2002) . However, enzyme known as CaaX prenyltransferases) recognize a CaaX motif where C is a cysteine residue, a is a small aliphatic amino acid, specificity is not absolutely stringent, and there are abundant examples of protein crossprenylation (Zhang and Casey, 1996) . and X is the carboxy-terminal residue that contributes to substrate specificity. These enzymes are heterodimeric complexes For instance, K-Ras4B oncoproteins presumably escape functional inhibition by FTase inhibitors (FTIs) due to geranylgerancomprised of a common regulatory (α subunit) and a unique catalytic (β subunit) subunit. In all cases, the isoprenyl group is ylation of its carboxy-terminal methionine by GGTase I (Lerner et al., 1997; Rowell et al., 1997; Whyte et al., 1997) . Other proattached to the protein by a thioether bond to the cysteine residue (Zhang and Casey, 1996) .
teins, such as RhoB, are substrates for both FTase and GGTase I (Armstrong et al., 1995) . More importantly, farnesylated RhoB Many substrates of CaaX prenyltransferases are involved in appears to have a different mechanism of action than its geranylgeranylated isoform (Du et al., 1999; Lebowitz et al., 1995) , thus indicating that protein isoprenylation may confer distinct biological properties, at least to certain substrates (reviewed in Prendergast, 2001) .
Among protein isoprenyltransferases, FTase has received special attention, since it is responsible for isoprenylating the Ras proteins implicated in a significant percentage of human cancers (reviewed in Downward, 2003; Sebti and Der, 2003) . Early structure/function studies had indicated that replacement of the cysteine residue present in the CaaX motif of Ras oncoproteins by serine completely abolished their transforming activity in vitro (Willumsen et al., 1984a; Willumsen et al., 1984b) . Later studies indicating that this cysteine residue was the site of modification by a farnesyl isoprenoid (Casey et al., 1989; Hancock et al., 1989) prompted the hypothesis that blocking farnesylation may have therapeutic benefit for cancer patients carrying ras oncogenes (reviewed in Gibbs et al., 1994) . FTIs inhibited or delayed tumor development in human tumor xenografts and in H-ras transgenic models (Kohl et al., 1995) with few toxic effects. Several FTIs were rapidly taken to the clinic, and some of them are in phase III clinical trials (Downward, 2003) . However, these compounds have not performed in the clinic to their initial expectations (Sebti and Der, 2003) . Moreover, the mechanism by which FTIs induce antitumor effects remains to be elucidated, since their antitumor spectrum does not correlate with the presence of ras oncogenes (Sebti and Der, 2003) .
We undertook this work to establish the genetic bases for the requirements of protein farnesylation in mammalian cells. To this end, we have generated constitutive (germline) and conditional (floxed) knockout strains of mice for the locus encoding the catalytic β subunit of FTase. We report here that protein farnesylation is essential for early embryonic proliferation but dispensable for postnatal development and adult homeostasis. Ablation of FTase in two ras oncogene-dependent tumor mod- null alleles resulting from partial and complete Cre-mediated recombination, respectively, of the loxneo allele is also indicated. The probe used to
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identify the diagnostic KpnI (K) and NheI (N) DNA fragments is indicated by a hatched box. Other diagnostic restriction sites, including EcoRI (E) and XbaI (X), are also indicated. a PGK-neo cassette (loxneo allele) ( Figure 1A ). Removal of exon 3 causes a shift in the open reading frame leading to the incorporation of 26 unrelated residues before encountering a stop termination codon within exon 4 sequences. Crosses bedetermined by Southern blot (data not shown) and PCR analytween FT +/loxneo and CMV-Cre transgenic mice (Schwenk et al., sis (Figures 1B and 1C) . Crosses between FT +/− mice failed to 1995) removed all floxed sequences to generate FT +/− heteroyield FT −/− animals. Crosses between FT +/lox mice resulted in zygous mice in 59 out of 62 newborn animals. In three mice, the generation of FT lox/lox animals with the expected Mendelian the Cre recombinase only removed the floxed PGK-neo casratio. These mice lived for over 2 years without obvious anasette, thus generating the desired conditional allele (lox allele). The presence of the null (−) and conditional (lox) alleles was tomical or behavioral abnormalities. FTase is essential for early embryonic development staining and increased apoptosis as revealed by high levels of TUNEL staining (Figure 2A ). Matings between FT +/− mice did not yield homozygous embryos at embryonic stage 11.5 (E11.5) or older. Histological exTo determine whether loss of FTase also had an effect on preimplantation embryos, we isolated E3.5 blastocysts from amination of decidual swellings at E7.5 revealed a significant percentage of highly disorganized embryos with gross morcrosses between FT +/− mice. After 48-72 hr in culture, all blastocysts behave equally well in culture regardless of their genophological alterations, including loss of the embryonic layers derived from the epiblast (Figure 2A ). Only structures related to type. They hatched and formed a multicomponent structure in which the inner cell mass (ICM) grew as a mound on top of the the ectoplacental cone and trophoblast giant cells could be morphologically identified. Loss of the epiblast in defective emextraembryonic trophoblast cells ( Figure 2B ). However, after 4 days in culture, a stage equivalent to E7.5 embryos, the ICM bryos appeared to be a consequence of decreased cell proliferation, as determined by a marked reduction of Ki67 immunoof FTase null embryos showed a dramatic decrease in cell pro-liferation ( Figure 2B ). These observations became even more evident 2 days later, when few FT −/− ICM cells persisted in the cultures and there was no detectable incorporation of bromodeoxyuridine (BrdU) ( Figure 2C ). In contrast, FT −/− trophoblasts remained attached to the culture dish and continued to grow in size at a rate similar to that of their wild-type counterparts, indicating that FTase may not be required for survival of endoreplicating cells (Figures 2B and 2C ). These observations suggest that the defects observed in FT −/− embryos are an intrinsic property of the mutant embryonic cells.
Growth properties of FTase-deficient mouse embryonic fibroblasts
Due to the early lethality of FT −/− embryos, we used conditional FTase mutant mice to generate primary cultures of mouse embryonic fibroblasts (MEFs). First, we crossed FT lox/lox animals with RERT ert/ert mice, a strain that carries an IRES-CreERT2 cassette (Brocard et al., 1997) inserted by homologous recombination at the 3# end of the locus encoding the large subunit of RNA polymerase II, between the terminator codon and the polyadenylation signal (ert allele). This strategy allows bicistronic expression of the inducible CreERT2 recombinase from the same mRNA as the large subunit of RNA polymerase II thanks to the knocked-in IRES sequences (our unpublished data).
Six independent cultures of FT
lox/lox
;RERT ert/ert MEFs derived from three different embryos were cultivated in the presence of 4-hydroxy-tamoxifen (4OHT), a synthetic steroid needed to activate CreERT2. Fully immortalized cultures were submitted to Southern blot analysis to determine whether the conditional lox allele had been completely excised. As illustrated in Figure 3A , all cultures contained varying amounts of null and lox alleles. To obtain a pure population of FT null MEFs, we isolated single-cell clones and submitted them to PCR analysis ( Figure 3B ). All 15 clones depicting an unambigu- motility in an in vitro wound closure assay ( Figure 3D ). tion ( Figure 3F ). However, the percentage of cells that entered S phase was reduced by about 60% when compared with that observed with FT
;RERT ert/ert MEFs ( Figure 3F Figure 4A ). We also assayed FTase activity in with putative FTase activity. Thus, we examined whether ;RERT ert/ert MEFs lack endogenous MDJ2, a chaperone protein known to be a FTase FTase activity. substrate (Davis et al., 1998) . As illustrated in Figure 4B, ;RERT ert/ert mice were exposed to 4OHT determined.
for 8 weeks. At the end of treatment, FT lox alleles had been Next, we determined the ability of these FTase-deficient cells efficiently excised in all tissues except muscle ( Figure 5A) wounds were covered with a dry scab. All wounds were healed by day 9 in control mice. ;RERT ert/ert animals (n = 6) resulted in size of their spleens. Moreover, FTase-defective spleens had a a significant increase in the size of their spleens after 48 hr. significantly larger pool of proliferating Ter119 + erythroid cells This increase was more pronounced in wild-type mice (from 142 ± 7 to 245 ± 2 mg, 72% increase) than in those mice lack-(7.7% ± 1.7% of total spleen cells versus 1.8% ± 0.5% in con- mice, no such increase could be observed in FTase-defective animals ( Figure 6B ). No differences were observed in Ter119 + , GR1 + , and CD11b + cells in bone marrow and peripheral blood before or after bleeding.
Ablation of FTase in tumors harboring K-ras oncogenes
To assess whether loss of FTase activity had an effect on tumor development, we ablated FTase in mice carrying lung adenocarcinomas induced by an endogenous K-ras oncogene (Guerra et al., 2003 ; RERT ert/ert mice (n = 18) were treated with 4OHT for 24 weeks. Both cohorts developed multiple lung adenomas and adenocarcinomas at about 7 months of age (Guerra et al., 2003) . As illustrated in Figure 7A , the number and size of adenomas present in both groups of mice were similar. Moreover, the percentage of adenomas that had progressed to adenocarcinomas at the time of death was also similar in both cohorts (22% in con- ;RERT ert/ert (filled columns) (n = 9) and FT ⌬ ;K-ras
;RERT ert/ert (open columns) (n = 9) mice.
RERT
ert/ert mice, including occasional facial and anal papillo- with a single dose of DMBA followed by treatment with TPA for 12 additional weeks. FT ⌬ ;RERT ert/ert (n = 18) mice were generated by treatment of , 1997) . Whether crossprenylation is responsible for the lack of effect of eliminating FTase in K-ras-induced tumors remains to be determined. In contrast, H-Ras cannot be isoprenylated by GGTase I treated or treated with 4OHT for 20 weeks to remove the FT (James et al., 1995) (Figure 4D ). Therefore, we examined the lox allele. When these mice became 2 months old, both corequirement of FTase for H-ras-induced oncogenesis in vivo.
Loss of FTase does not prevent activation of H-ras
horts were exposed to a single dose of DMBA (25 g/mouse) To this end, we submitted FTase-defective mice to the classical followed by repeated exposure to TPA for 12 additional weeks. 7,12 dimethyl-benzanthracene (DMBA) plus 12-o-tetradecaAs illustrated in Figure 7C , both cohorts of mice developed noylphorbol-13-acetate (TPA) skin carcinogenesis protocol in skin papillomas with similar incidence and kinetics regardless which H-ras oncogenes are frequently activated (Balmain and of the presence or absence of FTase. Genetic analysis of indiviPragnell, 1983).
dual papillomas (n = 9) isolated from FT D ;RERT ert/ert mice reWe first examined whether ablation of FTase before exposure vealed that the FT lox alleles had been completely excised in to DMBA had a benefit in tumor prevention. 
RERT
ert/ert mice with equal incidence (5 out of 9 and 6 out of 11 papillomas, respectively). All H-ras oncogenes were activated by the same CAA/CTA transversion in codon 61 (see the Supplemental Data available with this article online). We did not observe any significant differences in the size or pathological appearances between those tumors harboring H-ras oncogenes and those negative for this oncogene. These observations indicate that loss of the β subunit of FTase does not protect mice from skin tumor development, regardless of whether such tumors contain H-ras oncogenes or are induced by different mechanisms.
FTase ablation during tumor development
We also examined whether loss of FTase activity after tumor initiation had therapeutic benefit. Mice (n = 36) were either treated or not treated with 4OHT 2 weeks after the carcinogenic insult, a time when papillomas were still undetectable. At 15 weeks, both groups of mice had developed a similar number of papillomas ( Figure 7D expressed in papillomas lacking FTase was associated with the membranous P100 fraction ( Figure 8B ). As expected, the percentage of H-Ras protein present in the membrane fraction of Discussion control papillomas was close to 90% ( Figure 8B ). To determine whether the membrane localization of H-Ras in the absence of Available evidence indicates that eukaryotic genomes, from FTase is a unique property of papillomas or even a conseyeast to humans, encode a single FTase made up of a specific quence of its oncogenic activation, we determined the subcelcatalytic subunit (β subunit) and a regulatory subunit (α sublular localization of H-Ras in MEFs lacking FTase, a cell type in unit) shared with GGTase I. In agreement with these observawhich H-Ras does not incorporate farnesyl residues (see Figtions , ablation of the third exon of the gene encoding its β subures 4C and 4D). As shown in Figure 8C , the endogenous unit results in complete loss of FTase activity, as determined H-Ras protein expressed in FT −/− ;RERT ert/ert MEFs is also asby using three different substrates including H-Ras. In yeast, sociated with membranous structures. Ectopic overexpression FTase-deficient cells are viable but display significant growth of H-Ras in these cells results in the presence of a limited perdefects (Powers et al., 1986) . The viability of these cells has centage of the total H-Ras protein in the soluble fraction, a been attributed to compensatory mechanisms involving crossproperty also observed in control FT lox/lox ;RERT ert/ert MEFs prenylation by GGTase I (Trueblood et al., 1993) . FTase-defi-( Figure 8C ). These observations challenge the widely held concient MEFs proliferate well, but their growth rate is significantly cept that farnesylation is required for the association of H-Ras slower than that of wild-type cells. Moreover, quiescent FTase with membranes and for malignant transformation, at least in null MEFs do not reenter the cell cycle upon mitogenic stimuli as efficiently as their normal counterparts, suggesting a signalskin tumors.
ing defect possibly involving inefficient activation of Ras proin mice results in either late embryonic or early postnatal lethality (Kim et al., 1999) . The longer survival of rce1 null embryos teins. However, it is also possible that lack of farnesylation of certain cell cycle proteins, such as the CENP kinetochore procompared to those lacking FTase is likely to be due to substrate proteins retaining partial function, since they can be isoteins, may contribute to this phenotype. FTase-deficient MEFs have a flat polygonal appearance and fail to grow as dense prenylated even though postprenylation processing is abolished. rce1 null MEFs also displayed retarded growth, at least cultures. Moreover, their motility in standard in vitro wound assays is compromised, suggesting cytoskeletal defects (Zhang partially due to the compromised association of Ras proteins with cellular membranes (Bergo et al., 2002) . and Casey, 1996; Prendergast, 2001) .
In vivo, FTase null embryos proliferate well and are able to Removal of the aaX sequence exposes the α-carboxyl group of the farnesylcysteine residue to a specific isoprenylcysteine implant in the maternal uterus. However, they undergo massive apoptosis a few hours after implantation. In vitro, FTase-defimethyltransferase (ICMT). ICMT was first identified in S. cerevisiae as the product of STE14, a gene necessary for the prodcient blastocysts (E3.5) appear normal and proliferate well up to 5-6 days after fertilization. However, they cease proliferation uction of the a mating factor, but not for cell survival (Hrycyna et al., 1991) . A related gene, ICMT, has been recently identified thereafter, indicating that the strict requirement for FTase is a cell autologous property. These observations could be exin human cells and shown to be functionally equivalent (Dai et al., 1998) . Mice lacking Icmt die at about E10.5 (Bergo et al., plained by the absolute requirement of yet unidentified substrate(s) to undergo farnesylation during or immediately after 2001), a stage considerable later than that at which mice lacking FTase die. Icmt-defective fibroblasts grow more slowly than implantation. However, it is also possible that farnesylation may be essential for even earlier stages of embryonic cell prowild-type cells and are significantly resistant to transformation by K-ras oncogenes (Bergo et al., 2004) . Interestingly, this liferation, but such requirement is provided by the maternal enzyme. In either case, our results establish that FTase activity is property may not be a direct consequence of loss of activity of K-Ras but rather due to increased expression of the cell cycle essential for cell proliferation during early embryogenesis (at least after E5.5) and that such requirement cannot be compeninhibitor p21
Cip1
, since K-ras oncogenes can efficiently transform Icmt-defective MEFs lacking p21
Cip1 (Bergo et al., 2004) . sated by crossprenylation by either GGTase I or other protein isoprenyltransferases.
Moreover, Icmt null MEFs are also resistant to an oncogenic version of B-Raf, a nonprenylated protein that acts downProtein farnesylation, however, is not essential for postnatal development. Young animals lacking FTase in most of their stream of K-Ras (Bergo et al., 2004) . Much of the interest in protein farnesylation stemmed from tissues develop normally to adulthood. Remarkably, FT D ; RERT ert/ert male mice efficiently transmit their FT null allele to the hypothesis that this posttranslational modification may be essential for the transforming activity of Ras oncoproteins their offspring, demonstrating that FTase activity is not essential for meiotic cell division, at least in males. Likewise, liver (Zhang and Casey, 1996) . The limited success of FTIs in early clinical trials has dampened some of this enthusiasm (Downtissue regenerates in the absence of protein farnesylation after severe (70%) hepatectomy, regardless of the presence or abward, 2003; Sebti and Der, 2003) . These observations might be due, at least in part, to the fact that K-Ras4B, the Ras isoform sence of FTase activity. Young FTase-defective mice also recovered normally from other stress conditions, such as skin most frequently mutated in human cancer, can undergo crossprenylation by GGTase I and thus could be insensitive to FTase wounds and severe bleeding. Thus, unlike MEFs, postnatal fibroblasts respond normally to mitogenic stimuli. Likewise, heinhibition (Lerner et al., 1997; Rowell et al., 1997; Whyte et al., 1997) . Loss of FTase activity in lung adenomas induced by acmatopoiesis does not appear to be affected by lack of protein farnesylation in these young mice. These results suggest that tivation of an endogenous K-ras oncogene (Guerra et al., 2003) had no effect on either tumor incidence or tumor development. protein farnesylation may not be required after birth. Alternatively, farnesylated proteins may undergo crossprenylation in Whether these observations are due to alternative geranylgeranylation as suggested by the in vitro studies or to a different postnatal tissues more efficiently than in embryonic cells.
FTase is required for proper responses to stress conditions in mechanism remains to be elucidated. Unlike K-Ras, H-Ras proteins can only be isoprenylated by adult mice. Six-month-old FTase-deficient mice have delayed wound healing response (30% longer than wild-type animals).
FTase. Loss of FTase activity by postnatal ablation of the gene encoding the catalytic β subunit had no significant effect on These mutant mice also display delayed maturation of erythroid precursor cells, as determined by a significant increase skin tumor formation (papillomas) in the DMBA + TPA protocol, a tumor model known to involve the reproducible activation of proliferating progenitors in their spleens. This defect became more pronounced during response to severe bleeding. Howof H-ras oncogenes (Balmain and Pragnell, 1983) . Surprisingly, about two-thirds of these FTase-negative papillomas harbored ever, we did not observe significant defects in their bone marrow, suggesting that lack of FTase affects proliferation of com-H-ras oncogenes, the same percentage observed in FT lox/lox ; RERT ert/ert control mice. These observations indicate that, in a mitted erythroid precursors but not of pluripotent stem cells.
Protein farnesylation is the first step of a complex postphysiological environment, H-ras oncogenes contribute to tumor development in the absence of FTase activity. translational process required for proper biological activity of CaaX-containing proteins (Zhang and Casey, 1996) . FarnesyRemoval of FTase after initiation of tumorigenesis had a significant effect on tumor progression as both the number of lated proteins are recognized by specific endopeptidases that remove the carboxy-terminal aaX tripeptide (Boyartchuk et al., papillomas per animal and their average size were significantly reduced. Interestingly, those papillomas resistant to FTase ab-1997). In S. cerevisiae, this process is carried out by two independent zinc endopeptidases, Rce1 and Afc1 (Boyartchuk et lation still carried H-ras oncogenes and retained the same levels of H-Ras expression as control tumors expressing the al., 1997). The mammalian homolog of the yeast RCE1 gene has been recently isolated (Otto et al., 1999 CaaX motif by serine, a mutation that prevents farnesylation of the H-Ras oncoprotein (Casey et al., 1989; Hancock et al., Animal treatments
1989), abolished the transforming activity of retroviral v-H-ras
Mice were injected intraperitoneally three times a week with 0.5 mg of oilhomogenized 4OHT (Sigma). Two-month-old mice were hepatectomized as oncogenes in culture (Willumsen et al., 1984a; Willumsen et al., previously described (Higgins and Anderson, 1931 had no transforming activity, since they could not be properly were anesthetized, their backs were shaved, and a circular full-thickness localized in the plasma membrane. However, our results indiwound (6 mm in diameter) was created by excision of the skin with curved cate that H-Ras oncoproteins expressed in cells devoid of scissors. For bleeding experiments, 0.8 ml of blood was taken from the eye of 2-and 6-month-old animals. Before bleeding, an analgesic was adminFTase activity, and therefore presumed to be nonfarnesylated istrated. For carcinogenesis experiments, mice were treated with a single (see Figure 4 ), can associate with membranous structures and dose of DMBA (Sigma) (25 g for 10-week-old mice and 0.5 mg for P10 retain transforming activity, at least in DMBA-induced skin tumice) followed by exposure to TPA (Sigma) (12.5 g twice weekly) for a mors. These observations make it necessary to reexamine the total of 12 weeks. requirements for the association of H-Ras proteins with cellular membranes. We hypothesize that nonfarnesylated H-Ras pro- should help to establish the minimal requirements for their asMembrane (P100) and cytosolic (S100) fractions were isolated according to established protocols (Bergo et al., 2002) . H-Ras was immunoprecipitated sociation with membranous structures and for transforming acfrom 1 mg of P100 and S100 fractions with specific antibodies tivity.
(Ab-1; Oncogene Research Products). Western blots were performed using In summary, our observations illustrate that FTase is dispensdifferent H-Ras-specific antibodies (C20; Santa Cruz Biotechnology), or anable for tumor development induced by an endogenous K-ras tibodies against HDJ2 (MDJ2-human homolog, KA2A5.6; NeoMarkers) and oncogene, the ras oncogene most frequently activated in can-β-actin (AC-15; Sigma). Antibodies were detected with the appropriate cer patients. FTase is also dispensable for initiation of benign horseradish peroxidase-linked secondary antibody and visualized with an enhanced chemiluminescent (ECL) system (Amersham).
skin papillomas driven by H-ras oncogenes. However, removal of FTase after tumor initiation provides limited therapeutic ben- proaches such as those described here should help to define pared from MEFs as previously described (Fiordalisi et al., 2003 . H-Ras was immunoprecipitated as described above, resolved on 12% SDS-PAGE Gene targeting and genotyping strategies gels, and exposed to film. We have targeted the catalytic β subunit of FTase in ES cells by a strategy consisting in inserting three loxP sites flanking exon 3 and a PGK-neo casSupplemental data sette (loxneo allele) ( Figure 1A ). Detailed information regarding the generaThe Supplemental Data include Supplemental Experimental Procedures tion of the targeting vector as well as the PCR strategy to identify wild-type, and one supplemental figure and can be found with this article online at conditional (lox), and null (−) alleles can be found in the Supplemental Data.
http://www.cancercell.org/cgi/content/full/7/4/313/DC1/. Histology and cell culture assays E7.5 deciduas or adult tissues were surgically removed, fixed in 10% buffered formalin, and embedded in paraffin using standard procedures. SecAcknowledgments tions (6 m) were stained with hematoxylin and eosin (H&E). TUNEL assays were performed using the in situ cell death detection kit (Roche). Cell prolifWe thank Rut González, Marta San Román, and Raquel Villar for excellent technical assistance; Carmen Gómez, Marta Riffo, and Sagrario Ortega for eration was determined by immunostaining with anti-Ki67 antibodies (Biotechnologies). Blastocysts (E3.5) were collected by uterine flush with M2 their help with the generation of gene-targeted mice; Ignacio Segovia for his help with animal husbandry; Arantxa García, Diego Mejías, and María medium (Sigma) and individually cultured on gelatin-coated 96-well plates. For BrdU labeling, blastocysts were incubated for 2 hr with 10 M BrdU.
Montoya for their help with FACS analysis; and Lucía Pérez-Gallego for helpful discussions. The early phases of this work were carried out at the BrdU-positive cells were detected with BrdU detection kit I (Roche) according to the manufacturer's instructions. MEFs were isolated from FT lox/lox ; Centro Nacional de Biotecnología (CSIC; Madrid). We are indebted to M. Esteban and the Faculty for making their facilities available to us. This work RERT ert/ert E13.5 embryos and cultured in Dulbecco's modified Eagle's medium (DMEM) supplemented with 2 mM glutamine, 1% penicillin/streptomywas supported by grants from the V Framework Programme of the European Union (QLK3-1999-00875) to M.B. and from the Ministerio de Ciencia cin and 10% calf serum as described (Malumbres et al., 2004) in the absence or presence of 4OHT. Proliferation and S phase entry assays were y Tecnologia (SAF2001-0058) and Fondo de Investigación Sanitaria (00/
